The BioVox White Paper on Cancer Immunotherapy showcases innovators and world leaders in this exciting field, including GSK Biologicals, Janssen Immunosciences, Celyad, RXi Pharmaceuticals, eTheRNA, ImmunXperts, iTeos Therapeutics and PDC*line Pharma.
In this issue:
– Why is immunotherapy more than the latest hype?
– What are the challenges to bring lifesaving innovations to the patient?
– The price of life: who will pay for these treatments?
– Pioneering immunotherapy companies in the picture
– Insight in landmark oncology trials
– Academic innovations in immunotherapy
You will receive a link, immediately after submitting this form.
The BioVox platform is completely free! The only thing we ask in return is a bit more information about you and your fields of interest. This will allow us to provide more personalized information in the future.